Clinical and laboratory studies with selective monoamine-oxidase-inhibiting drugs. Implications for hypothesized neurotransmitter changes associated with depression and antidepressant drug effects

Mod Probl Pharmacopsychiatry. 1983:19:287-303.
No abstract available

MeSH terms

  • Behavior / physiology
  • Biogenic Amines / physiology*
  • Clorgyline / pharmacology
  • Depressive Disorder / drug therapy
  • Depressive Disorder / metabolism*
  • Dopamine / physiology
  • Histamine / physiology
  • Humans
  • Monoamine Oxidase Inhibitors / therapeutic use*
  • Norepinephrine / physiology
  • Pargyline / pharmacology
  • Phenethylamines / physiology
  • Selegiline / pharmacology
  • Serotonin / physiology
  • Tyramine / physiology

Substances

  • Biogenic Amines
  • Monoamine Oxidase Inhibitors
  • Phenethylamines
  • Selegiline
  • phenethylamine
  • Serotonin
  • Histamine
  • Pargyline
  • Clorgyline
  • Dopamine
  • Norepinephrine
  • Tyramine